Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical instillation of Botulinum toxin type A in patients with urge urinary incontinence
2008-006526-34Phase 2Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in urge incontinence and idiopathic detrusor overactivity (IDO), sponsored by Rigshospitalet Glostrup. Primary endpoint: Primary clinical effect of intravesical botulinum toxin type A. Started Nov 2008; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
urge incontinenceidiopathic detrusor overactivity (IDO)
Beyond the preview
Go deeper on 2008-006526-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006526-34.